C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/705 (2006.01) C07K 7/06 (2006.01) C07K 14/47 (2006.01) C07K 14/74 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01) C12Q 1/02 (2006.01) G01N 33/554 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2246222
Tumor rejection antigens presented by HLA-B44 molecules are described. These peptides are useful in diagnostic and therapeutic methodologies. The tumor rejection antigens are derived from MAGE tumor rejection antigen precursors.
La présente invention concerne des antigènes de rejet tumoral présentés par des molécules HLA-B44. Ces peptides sont utiles dans les procédés diagnostiques et thérapeutiques. Lesdits antigènes de rejet tumoral sont dérivés de précurseurs d'antigènes de rejet tumoral MAGE.
Boon-Falleur Thierry
Coulie Pierre
Herman Jean
Luescher Immanuel
Van Der Bruggen Pierre
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Ludwig Institute For Cancer Research
LandOfFree
Tumor rejection antigens presented by hla-b44 molecules, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor rejection antigens presented by hla-b44 molecules, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor rejection antigens presented by hla-b44 molecules, and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1363353